To determine whether SARS-CoV-2 Nsp15 similarly antagonizes type I and III IFN activation, we measured the mRNA levels of IFN-β (type I), IFN-λ3 (type III), and ISG56 in A549-A cells following infection. The gene discussed is IFNA1; the disease is infection.